Cargando…

Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel

Given the worldwide burden of neglected tropical diseases, there is ongoing need to develop novel anthelmintic agents to strengthen the pipeline of drugs to combat these burdensome infections. Many diseases caused by parasitic flatworms are treated using the anthelmintic drug praziquantel (PZQ), emp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chulkov, Evgeny G., Smith, Emery, Rohr, Claudia M., Yahya, Nawal A., Park, Sang-Kyu, Scampavia, Louis, Spicer, Timothy P., Marchant, Jonathan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565742/ https://www.ncbi.nlm.nih.gov/pubmed/34731172 http://dx.doi.org/10.1371/journal.pntd.0009898

Ejemplares similares

The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel
por: Park, Sang-Kyu, et al.
Publicado: (2019)

Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers
por: Gunaratne, Gihan S., et al.
Publicado: (2018)

Target-based discovery of a broad spectrum flukicide
por: Sprague, Daniel J., et al.
Publicado: (2023)

Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity
por: Rohr, Claudia M., et al.
Publicado: (2022)

Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel
por: Kasinathan, Ravi S., et al.
Publicado: (2014)

Human serum activates the tegument of female schistosomes and supports recovery from Praziquantel
por: Winkelmann, Franziska, et al.
Publicado: (2020)

The Anthelmintic Activity of Praziquantel Analogs Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
por: Sprague, Daniel J., et al.
Publicado: (2023)

TRP channels in schistosomes
por: Bais, Swarna, et al.
Publicado: (2016)

Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR
por: Smith, Emery, et al.
Publicado: (2020)

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
por: RUJENI, N, et al.
Publicado: (2012)

New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel
por: Walker, Martin, et al.
Publicado: (2016)

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
por: HUSSEIN, Atef, et al.
Publicado: (2017)

Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs
por: Levecke, B., et al.
Publicado: (2020)

Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents
por: Kasago, Freddy Mugisho, et al.
Publicado: (2023)

Schistosome TRP channels: An appraisal
por: Bais, Swarna, et al.
Publicado: (2020)

Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity
por: Smith, Emery, et al.
Publicado: (2020)

Schistosome migration in the definitive host
por: Nation, Catherine S., et al.
Publicado: (2020)

Cytokine Responses to the Anti-schistosome Vaccine Candidate Antigen Glutathione-S-transferase Vary with Host Age and Are Boosted by Praziquantel Treatment
por: Bourke, Claire D., et al.
Publicado: (2014)

Transcriptional Responses of In Vivo Praziquantel Exposure in Schistosomes Identifies a Functional Role for Calcium Signalling Pathway Member CamKII
por: You, Hong, et al.
Publicado: (2013)

Effect of four rounds of annual school‐wide mass praziquantel treatment for schistosoma mansoni control on schistosome‐specific immune responses
por: Ndombi, E. M., et al.
Publicado: (2018)

Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders
por: Mu, Yi, et al.
Publicado: (2021)

A secreted schistosome cathepsin B1 cysteine protease and acute schistosome infection induce a transient T helper 17 response
por: Soloviova, Kateryna, et al.
Publicado: (2019)

The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment
por: Koukounari, Artemis, et al.
Publicado: (2010)

Correction: Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomes in sub-Saharan Africa: a systematic review
por: Kabuyaya, Muhubiri, et al.
Publicado: (2023)

A Novel Biological Activity of Praziquantel Requiring Voltage-Operated Ca(2+) Channel β Subunits: Subversion of Flatworm Regenerative Polarity
por: Nogi, Taisaku, et al.
Publicado: (2009)

Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure
por: McCusker, Paul, et al.
Publicado: (2021)

Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist
por: Chan, John D., et al.
Publicado: (2016)

Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial
por: Tweyongyere, Robert, et al.
Publicado: (2011)

Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial
por: Tweyongyere, Robert, et al.
Publicado: (2009)

Atypical pharmacology of schistosome TRPA1-like ion channels
por: Bais, Swarna, et al.
Publicado: (2018)

Anti-schistosomal action of the calcium channel agonist FPL-64176
por: McCusker, Paul, et al.
Publicado: (2019)

Purinergic signaling in schistosomal infection
por: Silva, Claudia Lucia Martins
Publicado: (2016)

Resolution of Praziquantel
por: Woelfle, Michael, et al.
Publicado: (2011)

Schistosome immunomodulators
por: Acharya, Sreemoyee, et al.
Publicado: (2021)

Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias
por: Janovick, Jo Ann, et al.
Publicado: (2017)

Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer
por: Wang, Weixia, et al.
Publicado: (2020)

Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe
por: Mduluza, Takafira, et al.
Publicado: (2020)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

‘Death and Axes’: Unexpected Ca(2+) Entry Phenologs Predict New Anti-schistosomal Agents
por: Chan, John D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r1ttigf3lm9u2fr2unkpbla602